Abstract
(Abstracted from Obstet Gynecol 2022;139:157–162) Ovarian cancer represents a disproportionate amount of mortality associated with gynecologic malignancies, with more than 13,940 deaths annually. Two factors that significantly contribute to this are the phenomenon that most women are diagnosed at an advanced stage, and most develop recurrent and chemoresistant disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
